Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trazpiroben in symptomatic gastroparesis
NCT03544229Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Oct 2018
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of trazpiroben in gastroparesis, sponsored by Millennium Pharmaceuticals. Started Oct 2018; status: completed.
02
Drugs
trazpiroben
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT03544229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03544229.